National Institutes of Health
NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed)
UpcomingDecision brief
- Who can apply
- GovernmentHigher EducationOtherNonprofits (preferred)NonprofitsSmall Business
- Award amount
- $10K – $80K
- Deadline
- May 25, 2027
- Geography
- National
- Application notesHigh effort
- Federal application
- 4 awards expected — competitive
Next step
Apply at Grants.gov
Focus areas
About this grant
This Notice of Funding Opportunity (NOFO) solicits applications for the NLM Grants for Scholarly Works in Biomedicine and Health program. The program supports the preparation of book-length manuscripts and other scholarly works of academic and/or public health importance to U.S. health professionals, scientists, public health professionals, and other relevant audiences. This NOFO is intended to support scholars in producing critical reviews, analytical syntheses, and other integrative scholarly works that organize, contextualize, and disseminate biomedical and health-related knowledge. Through support for rigorous and integrative scholarship, the G13 program seeks to foster works that deepen understanding of current biomedical and public health challenges and contribute enduring resources for research, education, clinical practice, and public health.
Additional details
- CFDA / ALN Number
- 93.879
- Program Title
- Medical Library Assistance
- Expected Awards
- 4
- Estimated Total Funding
- Up to $320K
- Funding Instrument
- Grant
- Source
- Grants.gov · View original listing
Similar grants
Bureau of Global Health Security and Diplomacy
Advancing Global Health
$500K – $250MFeb 14, 2027AmeriCorps
Fiscal Year (FY) 2027 AmeriCorps State and National Competitive Grants
Jan 13, 2027AmeriCorps
Fiscal Year (FY) 2027 AmeriCorps Seniors RSVP Competition
6 days — Oct 20, 2026Health Resources and Services Administration
Fiscal Year (FY) 2027 Service Area Competition (SAC)
$650K – $10.1M5 days — Oct 19, 2026National Institutes of Health
Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional)
27 days — Nov 10, 2026National Institutes of Health
HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional)
Feb 9, 2029